Search
How Australia can invest in children and return more presents the opportunity for wise investments in evidence-based early intervention to radically change outcomes for Australian children and young people.
People living in poverty have insufficient household income to meet an acceptable standard of living, and are thus prevented from realising their full potential
Research
Immuno-nephelometric determination of group streptococcal anti-streptolysin O titres (ASOT) from dried blood spots: Method for validating a new assayThis study was designed to determine the sensitivity and reproducibility of recovering anti-streptolysin O titres (ASOT) from dried blood spot (DBS) samples.
Research
Incorporating Children's VoicesInforming urban planning and policy development to grow equitable access to healthy environments for young people and their families.
Research
Infants entering care: developmental needs and care trajectoriesMelissa O'Donnell BPsych (Hons), MPsych, GradDip Ed, PhD Honorary Research Associate Honorary Research Associate Areas of research expertise: Child
Research
Kids are not small adults, Identifying age-dependent drug targets in paediatric oncologyCancers in children are very different to cancers in adults. However, most therapeutic strategies are designed explicitly for adult cancers, and then used in children if proven safe.
Learn about those behind the LiLO research study
News & Events
New national role for The Kids’ Executive DirectorThe Australian Government has appointed the National Health and Medical Research Council (NHMRC) Council for 2024 to 2027.
News & Events
ORIGINS celebrates it’s 10,000th baby, reaching key recruitment milestoneAustralia’s biggest longitudinal study following the health and wellbeing of children from their conception through to childhood, has welcomed its 10,000th and final participant.
News & Events
New trial aims to reduce peanut allergy in childrenMothers eating a diet rich in peanuts while breastfeeding might be helping to reduce their baby’s risk of developing a peanut allergy – that’s the hypothesis of a new clinical trial that has been granted $2.29 million in funding by the National Health and Medical Research Council (NHMRC).